vs
HomeTrust Bancshares, Inc.（HTB）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是HomeTrust Bancshares, Inc.的1.3倍（$69.8M vs $53.6M），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 3.7%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 3.5%）
HomeTrust Bancshares, Inc.是总部位于美国北卡罗来纳州阿什维尔的银行控股公司，总资产达43亿美元，在北卡、南卡、佐治亚和田纳西州共设有33家网点，旗下拥有HomeTrust银行、Tryon联邦银行等七家社区银行。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
HTB vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.3倍
$53.6M
营收增速更快
RIGL
高出17.5%
3.7%
两年增速更快
RIGL
近两年复合增速
3.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $53.6M | $69.8M |
| 净利润 | — | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 37.0% | 33.2% |
| 净利率 | — | 384.0% |
| 营收同比 | 3.7% | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益（稀释后） | $0.93 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HTBRIGL
| Q4 25 | $53.6M | $69.8M | ||
| Q3 25 | $54.1M | $69.5M | ||
| Q2 25 | $54.4M | $101.7M | ||
| Q1 25 | $50.9M | $53.3M | ||
| Q4 24 | $51.7M | $57.6M | ||
| Q3 24 | $50.6M | $55.3M | ||
| Q2 24 | $50.6M | $36.8M | ||
| Q1 24 | $50.0M | $29.5M |
净利润HTBRIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | $16.5M | $27.9M | ||
| Q2 25 | $17.2M | $59.6M | ||
| Q1 25 | $14.5M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $13.1M | $12.4M | ||
| Q2 24 | $12.4M | $-1.0M | ||
| Q1 24 | $15.1M | $-8.2M |
毛利率HTBRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率HTBRIGL
| Q4 25 | 37.0% | 33.2% | ||
| Q3 25 | 38.5% | 40.9% | ||
| Q2 25 | 40.1% | 60.1% | ||
| Q1 25 | 36.2% | 23.9% | ||
| Q4 24 | 35.4% | 28.9% | ||
| Q3 24 | 33.2% | 25.4% | ||
| Q2 24 | 31.3% | 1.2% | ||
| Q1 24 | 38.0% | -23.6% |
净利率HTBRIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | 30.5% | 40.2% | ||
| Q2 25 | 31.6% | 58.6% | ||
| Q1 25 | 28.5% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | 25.9% | 22.5% | ||
| Q2 24 | 24.6% | -2.8% | ||
| Q1 24 | 30.1% | -27.9% |
每股收益（稀释后）HTBRIGL
| Q4 25 | $0.93 | $14.11 | ||
| Q3 25 | $0.95 | $1.46 | ||
| Q2 25 | $1.00 | $3.28 | ||
| Q1 25 | $0.84 | $0.63 | ||
| Q4 24 | $0.83 | $0.82 | ||
| Q3 24 | $0.76 | $0.70 | ||
| Q2 24 | $0.73 | $-0.06 | ||
| Q1 24 | $0.88 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $324.7M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $600.7M | $391.5M |
| 总资产 | $4.5B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资HTBRIGL
| Q4 25 | $324.7M | $155.0M | ||
| Q3 25 | $315.8M | $137.1M | ||
| Q2 25 | $297.2M | $108.4M | ||
| Q1 25 | $299.8M | $77.1M | ||
| Q4 24 | $279.2M | $77.3M | ||
| Q3 24 | $293.5M | $61.1M | ||
| Q2 24 | $294.2M | $49.1M | ||
| Q1 24 | $380.5M | $49.5M |
总债务HTBRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益HTBRIGL
| Q4 25 | $600.7M | $391.5M | ||
| Q3 25 | $595.8M | $117.6M | ||
| Q2 25 | $579.3M | $81.9M | ||
| Q1 25 | $565.4M | $18.6M | ||
| Q4 24 | $551.8M | $3.3M | ||
| Q3 24 | $540.0M | $-14.6M | ||
| Q2 24 | $523.6M | $-29.9M | ||
| Q1 24 | $513.2M | $-31.7M |
总资产HTBRIGL
| Q4 25 | $4.5B | $513.6M | ||
| Q3 25 | $4.6B | $242.5M | ||
| Q2 25 | $4.6B | $206.7M | ||
| Q1 25 | $4.6B | $176.0M | ||
| Q4 24 | $4.6B | $164.0M | ||
| Q3 24 | $4.6B | $139.4M | ||
| Q2 24 | $4.7B | $128.4M | ||
| Q1 24 | $4.7B | $126.5M |
负债/权益比HTBRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $49.5M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $45.3M | — |
| 自由现金流率自由现金流/营收 | 84.5% | — |
| 资本支出强度资本支出/营收 | 7.8% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $93.8M | — |
8季度趋势，按日历期对齐
经营现金流HTBRIGL
| Q4 25 | $49.5M | $22.0M | ||
| Q3 25 | $-11.3M | $24.0M | ||
| Q2 25 | $-8.8M | $30.5M | ||
| Q1 25 | $71.7M | $-893.0K | ||
| Q4 24 | $45.4M | $14.5M | ||
| Q3 24 | $43.8M | $21.7M | ||
| Q2 24 | $5.9M | $302.0K | ||
| Q1 24 | $-9.0M | $-5.0M |
自由现金流HTBRIGL
| Q4 25 | $45.3M | — | ||
| Q3 25 | $-12.0M | — | ||
| Q2 25 | $-10.2M | — | ||
| Q1 25 | $70.7M | — | ||
| Q4 24 | $42.4M | — | ||
| Q3 24 | $43.1M | — | ||
| Q2 24 | $5.7M | — | ||
| Q1 24 | $-9.6M | — |
自由现金流率HTBRIGL
| Q4 25 | 84.5% | — | ||
| Q3 25 | -22.2% | — | ||
| Q2 25 | -18.7% | — | ||
| Q1 25 | 138.7% | — | ||
| Q4 24 | 82.0% | — | ||
| Q3 24 | 85.1% | — | ||
| Q2 24 | 11.2% | — | ||
| Q1 24 | -19.2% | — |
资本支出强度HTBRIGL
| Q4 25 | 7.8% | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 5.9% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 0.5% | — | ||
| Q1 24 | 1.1% | — |
现金转化率HTBRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | -0.68× | 0.86× | ||
| Q2 25 | -0.51× | 0.51× | ||
| Q1 25 | 4.93× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 3.34× | 1.75× | ||
| Q2 24 | 0.48× | — | ||
| Q1 24 | -0.60× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
